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A Novel Mode of Action for a Microbial-Derived Immunotoxin: The Cytolethal
Distending Toxin Subunit B Exhibits Phosphatidylinositol 3,4,5-Triphosphate
Phosphatase Activity
Abstract
The Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt) is a potent immunotoxin
that induces G2 arrest in human lymphocytes. We now show that the CdtB subunit exhibits
phosphatidylinositol (PI)-3,4,5-triphosphate phosphatase activity. Breakdown product analysis indicates
that CdtB hydrolyzes PI-3,4,5-P3 to PI-3,4-P2 and therefore functions in a manner similar to
phosphatidylinositol 5-phosphatases. Conserved amino acids critical to catalysis in this family of
enzymes were mutated in the cdtB gene. The mutant proteins exhibit reduced phosphatase activity along
with decreased ability to induce G2 arrest. Consistent with this activity, Cdt induces time-dependent
reduction of PI-3,4,5-P3 in Jurkat cells. Lymphoid cells with defects in SHIP1 and/or ptase and tensin
homolog deleted on chromosome 10 (PTEN) (such as Jurkat, CEM, Molt) and, concomitantly, elevated
PI-3,4,5-P3 levels were more sensitive to the toxin than HUT78 cells which contain functional levels of
both enzymes and low levels of PI-3,4,5-P3. Finally, reduction of Jurkat cell PI-3,4,5-P3 synthesis using the
PI3K inhibitors, wortmannin and LY290004, protects cells from toxin-induced cell cycle arrest. Collectively,
these studies show that the CdtB not only exhibits PI-3,4,5-P3 phosphatase activity, but also that toxicity
in lymphocytes is related to this activity. Copyright © 2007 by The American Association of
Immunologists, Inc.
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A Novel Mode of Action for a Microbial-Derived
Immunotoxin: The Cytolethal Distending Toxin Subunit
B Exhibits Phosphatidylinositol 3,4,5-Triphosphate
Phosphatase Activity1
Bruce J. Shenker,2* Mensur Dlakić,‡ Lisa P. Walker,* Dave Besack,* Eileen Jaffe,¶ Ed LaBelle,§
and Kathleen Boesze-Battaglia†

T

he cytolethal distending toxins (Cdts)3 are a family of
heat-labile protein cytotoxins produced by several different bacterial species including diarrheal disease-causing
enteropathogens such as some Escherichia coli isolates, Campylobacter jejuni, Shigella species, Haemophilus ducreyi, and Actinobacillus actinomycetemcomitans (1–7). There is clear evidence
that Cdts are encoded by three genes, designated cdtA, cdtB, and
cdtC, which are arranged as an apparent operon (7–12). These
three genes specify three polypeptides designated CdtA, CdtB, and
CdtC with apparent molecular masses of 28, 32, and 20 kDa, respectively, that form a heterotrimeric holotoxin. Several cell lines
and cell types have been shown to be sensitive to Cdt; these include human lymphoid cells, fibroblasts, human embryonic intestinal epithelial cells, a human colon carcinoma cell line, and human keratinocytes, among others (7, 11, 12). In response to Cdt,
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most of these cells exhibit G2 arrest, cellular distension, and eventually cell death. However, the effects of Cdt on lymphocytes are
different; Cdt-treated lymphocytes do not exhibit cellular distension and are nearly five orders of magnitude more sensitive to Cdt
(10 –50 pg/ml) relative to most other cells (1–5 g/ml). For this
reason, we believe that lymphocytes are a likely in vivo target of
Cdt and propose that Cdt represents a novel immunotoxin.
The underlying basis for heightened lymphocyte sensitivity to
Cdt remains unclear. However, there is considerable agreement
that regardless of the microbial source of Cdt, the heterotrimeric
holotoxin functions as an AB2 toxin where CdtB is the active (A)
unit and the complex of CdtA and CdtC comprise the binding (B)
unit (13–15). In this regard, we have shown that CdtA and CdtC
are required for the toxin to associate with lipid microdomains
within lymphocyte membranes and that Cdt-mediated toxicity is
dependent upon the integrity of these lipid domains (16). We have
also demonstrated that CdtB is capable of inducing G2 arrest and
eventually apoptotic death in both mitogen-activated human T
cells and T cell leukemia cell lines such as Jurkat (8, 9). There is
compelling evidence that CdtB must be internalized to induce cell
cycle arrest (17–19). Several investigators have also suggested
that CdtB functions as a DNase-like moiety whereby it cleaves
DNA and activates the G2 cell cycle checkpoint (18, 20, 21). This
mechanism of action, however, does not account for the huge difference in lymphocyte sensitivity to the toxin. Although it has
been shown that Cdt-treated cells exhibit DNA degradation, we
have shown that Cdt-induced DNA fragmentation in lymphocytes is not the result of direct effects of the toxin, but rather the
irreversible effects of cell cycle arrest leading to activation of
the apoptotic cascade (22).
The bias in recent literature toward rationalizing CdtB function is
mostly based on its homology with DNase. This bias has obscured the
fact that its protein fold, and most likely the reaction mechanism, are
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The Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt) is a potent immunotoxin that induces G2 arrest in
human lymphocytes. We now show that the CdtB subunit exhibits phosphatidylinositol (PI)-3,4,5-triphosphate phosphatase activity. Breakdown product analysis indicates that CdtB hydrolyzes PI-3,4,5-P3 to PI-3,4-P2 and therefore functions in a manner
similar to phosphatidylinositol 5-phosphatases. Conserved amino acids critical to catalysis in this family of enzymes were mutated
in the cdtB gene. The mutant proteins exhibit reduced phosphatase activity along with decreased ability to induce G2 arrest.
Consistent with this activity, Cdt induces time-dependent reduction of PI-3,4,5-P3 in Jurkat cells. Lymphoid cells with defects in
SHIP1 and/or ptase and tensin homolog deleted on chromosome 10 (PTEN) (such as Jurkat, CEM, Molt) and, concomitantly,
elevated PI-3,4,5-P3 levels were more sensitive to the toxin than HUT78 cells which contain functional levels of both enzymes and
low levels of PI-3,4,5-P3. Finally, reduction of Jurkat cell PI-3,4,5-P3 synthesis using the PI3K inhibitors, wortmannin and
LY290004, protects cells from toxin-induced cell cycle arrest. Collectively, these studies show that the CdtB not only exhibits
PI-3,4,5-P3 phosphatase activity, but also that toxicity in lymphocytes is related to this activity. The Journal of Immunology, 2007,
178: 5099 –5108.
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Table I. CdtB mutant constructs
Plasmid

Primer

Sequencea

pGEMCdtBH160Q

P1
P2
P1
P2
P1
P2
P1
P2

GTATTTTTTACAGTGCAGGCTTTGGCCACA
TGTGGCCAAAGCCTGCACTGTAAAAAATAC
CAAATTACATCCGATCAGTTTCCTGTTAGTTTTGT
ACAAAACTAACAGGAAACTGATCGGATGTAATTTG
GATGTTGGGGCAAACGCAGTGAACTTAGCTATCG
CGATAGCTAAGTTCACTGCGTTTGCCCCAACATC
GATGGTTGTTGGTAGTTTCAATCGTGCGCCGGT
ACCGGCGCACGATTGAAACTACCAACAACCATC

pGEMCdtBH274Q
pGEMCdtBR117A
pGEMCdtBD199S
a

Bold letters in the sequence indicate nucleotide substitutions.

Materials and Methods
Cell lines and analysis of cell cycle
The human leukemic T cell lines Jurkat, CEM, and Molt were maintained
in RPMI 1640 supplemented with 10% FCS, 2 mM glutamine, 10 mM
HEPES, 100 U/ml penicillin, and 100 g/ml streptomycin. HUT78 cells
were maintained in IMDM containing 4 mM L-glutamine and 20% FCS.
Cells were harvested in mid-log growth phase and plated at 5 ⫻ 105 cells/
ml, or as indicated, in 24-well tissue culture plates. The cells were exposed
to medium, Cdt peptides, or CdtABC and incubated for 18 h. To measure
Cdt-induced cell cycle arrest, Jurkat cells were washed and fixed for 60 min
with cold 80% ethanol (27). After washing, the cells were stained with 10
g/ml propidium iodide containing 1 mg/ml RNase (Sigma-Aldrich) for 30
min. Samples were analyzed on a BD Biosciences FACStarPLUS flow cytometer (BD Biosciences). Propidium iodide fluorescence was excited by
an argon laser operating at 488 nm and fluorescence measured with a 630/
22-nm bandpass filter using linear amplification. A minimum of 15,000
events were collected on each sample; cell cycle analysis was performed
using Modfit (Verity Software House).

Construction and expression of CdtB mutants
Amino acid substitutions were introduced into the cdtB gene by in vitro
site-directed mutagenesis using oligonucleotide primer pairs containing appropriate base changes (Table I). Site-directed mutagenesis was performed
using the QuikChange II site-directed mutagenesis kit (Stratagene) according to the manufacturer’s directions. Amplification of the mutant plasmid
was conducted using PfuUltra HF DNA polymerase (Stratagene) and
pGEMCdtB as a template; construction and characterization of this plasmid was previously described (27). All mutants were verified by DNA
sequencing. Expression of the plasmids and purification of the mutant peptides is described below.

Expression and purification of Cdt peptides and Cdt holotoxin
(CdtABC)
Construction and expression of the plasmid containing wild-type cdtB gene
(pGEMCdtB) was previously described (27). In vitro expression of Cdt
peptides and CdtB mutants was performed as previously described using
the Rapid Translation System (RTS 500 ProteoMaster; Roche Applied Science). Reactions were run according to the manufacturer’s specification
(Roche Applied Science) using 10 –15 g of template DNA. After 20 h at
30°C, the reaction mix was removed and the expressed Cdt peptides were
purified by nickel affinity chromatography as described (27).
Construction and expression of the plasmid containing the cdt genes for
the holotoxin (pUCAacdtABChis) has previously been reported (28). The
plasmid was constructed so that the cdt genes were under control of the lac
promotor and transformed into E. coli DH5␣. Cultures of transformed E.
coli were grown in 1 L Luria-Bertani broth and induced with 0.1 mM IPTG
for 2 h; bacterial cells were harvested, washed, and resuspended in 50 mM
Tris (pH 8.0). The cells were frozen overnight, thawed, and sonicated. The
histidine-tagged peptide holotoxin was isolated by nickel affinity chromatography as previously described (9).

FIGURE 1. Structural alignment. Structural alignment of CdtB, inositol polyphosphate 5-phosphatase (IP5P), and DNase I was obtained by MUSTANG
and slightly modified after visual inspection of superimposed structures. Protein Data Bank codes of corresponding structures are shown in parentheses next
to protein names. The consensus line indicates the conservation of small (s), aliphatic (l), hydrophobic (h), charged (c), positive (⫹), and negative (⫺)
residues, whereas identical residues are shown as capital letters. Numbers in parentheses within the alignment indicate the residues that were omitted either
because of long insertions not shared by all proteins or for the lack of reliable alignment between the three structures. Amino acid residues mutated in this
study are marked by red triangles. The remaining residues that are important for catalysis or Mg2⫹ coordination are identified by blue diamonds.
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also shared with many proteins found in a family of functionally unrelated signaling metalloenzymes that includes phosphatidylinositol
(PI)-5-phosphatases (23). In this study we considered other possible
modes of action for CdtB and explored the possibility that CdtB might
function as a phosphatase (24). Indeed, we now report that CdtB exhibits PI-3,4,5-triphosphate (PI-3,4,5-P3) phosphatase activity similar
to that of the tumor suppressor phosphatases, ptase and tensin homolog deleted on chromosome 10 (PTEN) and SHIP1 (25, 26). Mutation analysis indicates that Cdt toxicity correlates with phosphatase
activity; furthermore, lymphocytes treated with toxin exhibit reduced
PI-3,4,5-P3 levels. Finally, lymphocyte sensitivity to Cdt-induced G2
arrest correlates with intracellular levels of PI-3,4,5-P3.
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Phosphatase assay

Measurement of cellular PI-3,4,5-P3 content

Phosphatase activity was assessed by monitoring the dephosphorylation of
PI-3,4,5-P3 as described by Maehama et al. (29). Briefly, the reaction mixture (20 l) consisted of 100 mM Tris-HCl (pH 8.0), 10 mM DTT, 0.5 mM
diC16-phosphatidylserine (Avanti), 25 M PI-3,4,5-P3 (diC16; Echelon),
and the indicated amount of CdtB, CdtABC, or PTEN (provided by G.
Taylor, University of Nebraska Medical Center, Omaha, NE). Appropriate
amounts of lipid solutions were deposited in 1.5-ml tubes, organic solvent was
removed, the buffer was added, and a lipid suspension was formed by sonication. For experiments to determine substrate specificity, PI-3,4,5-P3 was replaced by the indicated phosphatidylinositol phosphate (Echelon). Phosphatase
assays were conducted at 37°C for 30 min; the reactions were terminated by
the addition of 15 l of 100 mM N-ethylmaleimide. Inorganic phosphate levels
were then measured using a malachite green assay. Malachite green solution
(Biomol Green; Biomol) was added to 100 l of the enzyme reaction mixture
and color was developed for 20 min at room temperature (RT). Absorbance at
650 nm was measured and phosphate release was quantified by comparison to
inorganic phosphate standards.

Jurkat cells (5 ⫻ 105/ml) were incubated in the presence of medium or Cdt
holotoxin for 30 –240 min. Replicate cultures (1 ⫻ 107 cells) were pooled
and harvested. The cell pellet was treated with cold 0.5 TCA for 5 min,
centrifuged, and the pellet was washed twice with 5% TCA containing 1
mM EDTA. Neutral lipids were extracted twice with methanol:chloroform
(2:1) at RT. Acidic lipids were extracted with 2.25 ml of methanol:chloroform:12 M HCl (80:40:1) for 15 min at RT; the samples were centrifuged
for 5 min and the supernatant was recovered. The supernatant was then
treated with 0.75 ml of chloroform and 1.35 ml of 0.1 M HCl and centrifuged
to separate organic and aqueous phases; the organic phase was collected and

Analysis of CdtB-mediated product formation
Inositol lipids were separated by thin layer chromatography. Silica gel G
plates were dipped in boric acid (5% in methanol) and then dried. They
were then spotted with the lipid samples dissolved in chloroform/methanol/
water (1/2/0.1) together with solutions containing the standard inositol lipids phosphatidyl 4,5 bisphosphate, phosphatidyl 3,4 bisphosphate, phosphatidyl 3,5 bis phosphate, phosphatidyl 3,4,5 triphosphate, and PI. The
plates were eluted with solutions containing propyl acetate/isopropanol/
ethanol/ammonia/water (15/45/16/9/35), dried, and sprayed with solution
containing CuSO4/H3PO4 (8%/10%), and air dried again. Plates were then
heated to 70°C then to 155°C to visualize the lipids.

DNase assay
CdtB peptides were assessed for DNase activity by monitoring changes in
electrophoretic mobility of supercoiled plasmid DNA as described by Elwell and Dreyfus (20). Briefly, supercoiled pUC19 (1 g/reaction) was
incubated with CdtB, CdtB mutants, or bovine DNase I for 2 h at 37°C in
a buffer containing 25 mM HEPES (pH 7.0), 10 mM MgCl2, and 5 mM
CaCl2. The reaction was stopped by adding 10 mM EDTA (final concentration). The samples were then loaded onto 1% agarose gel and subjected
to electrophoresis in Tris-Borate-EDTA buffer; gels were stained with
ethidium bromide and analyzed by digital scanning densitometry.

FIGURE 3. Analysis of substrate specificity and product formation for
both CdtB and PTEN. CdtB (0.5 M; f) and PTEN (0.1 M; 䡺) were
incubated for 30 min in presence of liposomes containing one of the PI
phosphates shown. Data are plotted as phosphate release (nM/30 min;
mean ⫾ SD) for each substrate. It should be noted that no phosphate release was observed in presence of phosphatidylserine alone. Inset, Results
from TLC analysis of product formation following PI-3,4,5-P3 hydrolysis
in the presence of 0.5 M CdtB or 0.1 M PTEN.
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FIGURE 2. CdtB exhibits PI-3,4,5P3 phosphatase activity. As shown in A,
varying amounts of CdtB (Œ), CdtABC
(f), and PTEN (F) were assessed for
their ability to hydrolyze PI(3,4,5)-P3
as described in Materials and Methods.
The amount of phosphate release was
measured using a malachite greenbinding assay. Data are plotted as phosphate release (nM/30 min; mean ⫾ SD)
vs protein concentration; numbers
shown are ED0.5 values defined as the
concentration required to induce ⬃50%
(0.5 nM) phosphate release under these
assay conditions. B, The rate of CdtB
(0.5 M) and PTEN (0.1 M) mediated phosphate release in the presence
of varying concentrations of PI-3,4,5P3 was assessed. Data were analyzed
using Michaelis-Menten kinetics. The
Km values for CdtB and PTEN were
124.3 and 159.1 M, respectively;
Vmax were 0.55 nM/min (CdtB) and
0.087 nM/min (PTEN).
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FIGURE 4. Effect of phosphatase inhibitors on CdtB-mediated hydrolysis of PI-3,4,5-P3. CdtB (0.5 M; Œ) and PTEN (0.1 M; F) were incubated with liposomes containing PI-3,4,5-P3 in the presence of varying
concentrations of tungstate (A) or orthovanadate (B) for 30 min. Phosphate
release was measured using the malachite green-binding assay. Results are
plotted as phosphate release (nM/30 min; mean ⫾ SD) vs inhibitor concentration (millimoles).

dried. The dried lipids were resuspended in 120 l of 50 mM HEPES buffer
(pH 7.4) containing 150 mM NaCl and 1.5% sodium cholate, and left overnight at 4°C. PI-3,4,5-P3 levels were then determined using a commercially
available competitive ELISA according to the manufacturer’s directions (PIP3
Mass ELISA kit; Echelon).

Structural comparisons
Multiple structural alignment of CdtB from A. actinomycetemcomitans
with inositol polyphosphate 5-phosphatase and DNase I was made using
MUSTANG (www.cs.mu.oz.aw/⬃arun/mustang/) (30 –33). Positional sequence conservation of CdtB was derived from combined alignments of
CdtB and inositol polyphosphate 5-phosphatase homologs (34) and residue
conservation was determined (35). Conservation indices were converted to
colors (red, most conserved; green, intermediate; blue, least conserved) and
mapped onto the CdtB structure using Bobscript (36).

Results
It has been proposed, based on sequence comparisons, that CdtB
shares catalytic residues and similar reaction mechanism with the
large group of functionally diverse Mg2⫹-dependent phosphoesterases (23). DNase I was the first structurally characterized member of this diverse enzyme superfamily (32); subsequent structural
characterization of inositol polyphosphate 5-phosphatases and
CdtB confirmed the initial prediction (13, 30, 31). An alignment of
these three structures shows striking conservation of catalytic and
divalent ion-chelating residues, despite low overall sequence iden-

tity (Fig. 1). As a general rule, all enzymes in this superfamily
hydrolyze phosphate esters and their exact function depends on
what substrate(s) can be accommodated in the active site. CdtB
was originally characterized as a DNase-like enzyme and the putative PI phosphatase activity was never formally tested despite its
weak nuclease activity (18).
In this study, CdtB was initially assessed for its ability to dephosphorylate PI-3,4,5-P3. As shown in Fig. 2A, CdtB exhibits
dose-dependent (0.2–1.0 M) phosphate release which ranged
from 0.1 to 0.9 nM in the presence of 0.2 and 1.0 M CdtB,
respectively. It should be noted that CdtA and CdtC failed to exhibit phosphatase activity under identical conditions (data not
shown). The Cdt holotoxin (CdtABC), containing all three subunits, exhibited dose-dependent activity similar to that of CdtB.
ED0.5 values (concentration required to catalyze 0.5 nM phosphate
release) were calculated; the ED0.5 for CdtB and the holotoxin
were 0.5 and 0.38 M, respectively. For comparative purposes,
PTEN was also assessed for activity. PTEN exhibited dose-dependent (0.02– 0.2 M) phosphate release; thus, PTEN was determined to be ⬃10 times more active then CdtB with an ED0.5 of
0.05 M. To further explore the propensity of CdtB to act as a PI
phosphatase, we presumed a Michaelis-Menten relationship and
determined Km and Vmax values with respect to cleavage of PI3,4,5-P3 and compared it to a similar analysis of PTEN (Fig. 2B).
By this analysis, both CdtB and PTEN demonstrated similar Km
values of 124.3 and 159.1 M, respectively. Vmax values were
0.055 nM/min for 0.5 M CdtB and 0.087 nM/min for 0.1 M
PTEN. Thus, CdtB exhibits PI-3,4,5-P3 phosphatase activity that is
comparable to that of PTEN.
CdtB substrate specificity was assessed using several different
phosphoinositides. Preliminary experiments indicated that the lipid
moiety was critical for CdtB phosphatase activity when PI3,4,5-P3 was used as a substrate; therefore, all PIs contained
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FIGURE 5. Residue conservation. A look from above into the active
site of CdtB with mutated residues shown in ball-and-stick representation.
Individual alignments of CdtB and IP5P homologs were combined and residue
conservation was determined for each column of the alignment. Residues that
are most conserved between these two groups of proteins are colored in red,
with color shading changing toward green (for intermediate conservation) and
blue (lack of conservation). Despite very low pairwise sequence identity between these proteins, the active site shows remarkable degree of conservation
that reflects their similar reactions mechanisms.
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di-C16 acyl side chains. The PIs were incorporated into a lipid
bilayer with phosphatidylserine as the carrier lipid. As shown in
Fig. 3, CdtB-catalyzed phosphate release only occurred in the presence of PI-3,4,5-P3; neither phosphatidylinositol diphosphates nor
monophosphates were able to serve as a substrate. PTEN exhibited
substrate specificity for PI-(3,4,5)-P3 identical with CdtB. In other
experiments, we also determined that CdtB was unable to dephosphorylate inositol triphosphate or inositol tetrakisphosphate (data
not shown). It should also be noted that CdtB did not exhibit detectable protein phosphatase activity when the synthetic substrate,
p-nitrophenyl phosphate, was used (data not shown). Additional
similarities between PTEN and CdtB were observed with respect
to susceptibility to the phosphatase inhibitors, tungstate and orthovanadate. As shown in Fig. 4, tungstate reduced CdtB phosphatase activity in a dose-dependent fashion; phosphatase activity
was reduced 15% at 1 mM and 70% at 10 mM tungstate. Likewise,
orthovanadate inhibited CdtB by 10% at 1 mM and 85% at 10 mM.
PTEN exhibited similar dose-dependent sensitivity to these inhibitors.
It should be noted that molybdate failed to inhibit CdtB or PTEN (data
not shown). To determine whether CdtB is a 3- or 5-phosphatase,
product formation was assessed using thin-layer chromatography. Al-

though both CdtB and PTEN share many properties, they differ with
respect to product produced. Whereas PTEN is specific for dephosphorylation at the D3 position of the inositol ring yielding PI-(4,5)-P2,
CdtB appears to be specific for the D5 position producing PI-(3,4)-P2
(Fig. 3, inset) suggesting that CdtB activity may more accurately reflect that of an inositol 5-phosphatase similar to SHIP.
To further explore the relationship between CdtB and inositol
polyphosphate 5-phosphatase, we generated several CdtB mutants
that involve amino acid substitutions in residues that correspond to
the inositol polyphosphate 5-phosphatase active site and which
have previously been shown to be crucial for CdtB toxin activity.
Fig. 5 shows a view into the active site of CdtB, with red color
corresponding to the best residue conservation estimated from the
combined alignment of CdtB and inositol polyphosphate 5-phosphatase homologs. The active site mutations included: CdtBH160Q,
CdtBH274Q, CdtBR117A, and CdtBD199S; positions of these residues
within the active site are shown in Fig. 5. The mutants were first
assessed for their ability to release phosphate from PI-(3,4,5)-P3.
As shown in Fig. 6A, each of the mutants was observed to catalyze
dose-dependent phosphate release; however, all of the mutants exhibited reduced activity relative to wild-type CdtB (CdtBWT);
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FIGURE 6. Analysis of CdtB mutants for PI-3,4,5-P3 phosphatase activity. Plasmids were constructed containing mutations at residues critical to the
putative active site: CdtBH160Q, CdtBH274Q, CdtBR117A, and CdtBD199S. The expressed proteins were purified and varying amounts of each were assessed
for their ability to hydrolyze PI-3,4,5-P3 (A): CdtBWT (F), CdtBH160Q (), CdtBH274Q (f), CdtBR117A (), and CdtBD199S (Œ). Data are plotted as phosphate
release (nM/30 min; mean ⫾ SD) vs protein concentration. B, The rate of phosphate release from PI-3,4,5-P3 was assessed for mutants involving the
catalytic site: CdtBH160Q, CdtBH274Q, and CdtBD199S. No analysis was performed on the CdtBR117A mutants because of the low level of activity. Data were
analyzed using Michaelis-Menten kinetics; both Km and Vmax values are indicated in the respective panels.
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ED0.5 values increased from 0.3 M for CdtBWT to 1.9
(CdtBH160Q) 0.8 M (CdtBH274Q), 3.4 CdtBR117A and 1.5 M
(CdtBD199S). The Michaelis-Menten kinetic parameters were also
assessed for these mutations; as shown in Fig. 6B, the Km values
for the mutants was reduced to 68.9 (CdtBH160Q), 29.6
(CdtBH274Q), and 84.8 (CdtBD199S) while the Vmax was also reduced to 0.019, 0.023 and 0.018 nM/min, respectively. Phosphatase activity expressed by CdtBR117A was not sufficient to allow
for kinetic analysis. Fig. 7 compares the ability of CdtBWT along
with the CdtB mutants to exhibit DNase I-like activity using supercoiled plasmid DNA as a substrate. CdtBWT exhibited detectable nuclease activity although it was less than five orders of magnitude of that observed with bovine DNase I. All of the mutants,
with the exception of CdtBH274Q, exhibited a reduction in DNase

activity; in contrast, CdtBH274Q nuclease activity was comparable
to that of CdtBWT.
The ability of the mutants to induce G2 arrest in Jurkat cells was
also assessed. It should be noted that, as previously reported,
the ability of CdtB to induce G2 arrest requires the presence of CdtA
and CdtC; the combination of individual Cdt subunits produces an
active toxin that is not quite as potent (requiring nanograms of
each subunit) as when the three Cdt genes are coexpressed to form
a holotoxin (27). Thus, these experiments were done in the presence of CdtA and CdtC under conditions that we previously demonstrated results in an active toxin complex. As shown in Fig. 8,
13.9% G2 cells were observed in control cultures and 14.7% G2
cells in cultures exposed to only CdtA and CdtC; when 4 ng of
CdtBWT was added to CdtA and CdtC, the G2 population increased
to 54.8%. In comparison, all of the CdtB mutants lost the ability to
induce G2 arrest; the percentage of G2 in these cultures were
15.5% (CdtBH160Q), 15.8% (CdtBH274Q), 13.1% (CdtBR117A), and
15.3% (CdtBD199S). It should be noted that the mutants retained
residual toxicity if used at higher concentrations (micrograms per
milliliter). These experiments demonstrate a correlation between
decreased lipid phosphatase activity and loss of the toxins ability
to induce cell cycle arrest in lymphocytes.
To further define the relationship between lipid phosphatase activity and Cdt intoxication of lymphocytes, we used two lines of
investigation. We first demonstrated that exposure of Jurkat cells
to Cdt results in both a dose- and time-dependent reduction of the
intracellular levels of PI-3,4,5-P3. As shown in Fig. 9A, treatment
of Jurkat cells with a toxic dose of CdtABC (50 pg/ml) results in
a time-dependent reduction in PI-3,4,5-P3 levels from 8.3 pM/107
cells to 6.5 and 4.7 pM/107 cells within 15 and 30 min, respectively; levels were further reduced to 3.3 pM/107 cells at 120 min
and to 1.5 pM/107 cells at 240 min. Cdt treatment also induced a
dose-dependent reduction in PI-3,4,5-P3 levels when Jurkat cells

FIGURE 8. Assessment of CdtB mutants for their ability to induce G2 arrest in Jurkat cells. Jurkat cells were exposed to medium alone (A) or 10 ng/ml
each of CdtA and CdtC in the presence of 4 ng/ml CdtBWT (B) or CdtBH160Q (C), CdtBH274Q (D), CdtBR117A (E), or CdtBD199S (F). Cells were analyzed
for cell cycle distribution 18 h after exposure to toxin subunits using flow cytometric analysis of propidium iodide fluorescence (27). The numbers in each
panel represent the percentages of cells in G0/G1, S, and G2/M. Cells exposed to only 10 ng/ml each of CdtA and CdtC exhibited 14.7% G2 cells (data not
shown). Results are representative of three experiments.
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FIGURE 7. Analysis of CdtB mutants for DNase activity. CdtBWT and
each of the CdtB mutants (2.5 g) were incubated with supercoiled pUC19
DNA for 2 h at 37°C as described in Materials and Methods; bovine DNase
(1 pg) was used as a positive control. The samples were then subjected to
electrophoresis in agarose gels; after staining with ethidium bromide the
gels were analyzed by digital scanning densitometry. S and R refer to
supercoiled and relaxed form of plasmid DNA, respectively. Numbers reflect the relative density of the R band expressed as a percentage of the
control.
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FIGURE 9. Relationship between exposure to Cdt, toxicity, and cellular
content of PI-3,4,5-P3. A, Jurkat cells were incubated in the presence of 50
pg/ml CdtABC for varying periods of time. Cells were then harvested,
phospholipids were extracted, and PI-3,4,5-P3 levels determined by
ELISA. Data are plotted as PI-3,4,5-P3 content (pM/107 cells; mean ⫾ SD)
vs time. B, PI3K inhibitors were used to lower Jurkat cell PI-3,4,5-P3 and
thereby alter susceptibility to CdtABC. Jurkat cells were preincubated in
medium, 250 nM wortmannin, or 40 M LY290004. The cells were then
treated with medium or 40 pg/ml CdtABC and assessed for cell cycle
distribution by flow cytometry. The numbers in each panel represent the
percentages of cells in G0/G1, S, and G2/M.

were exposed to 50 –5000 pg/ml toxin for 2 h (data not shown). In
a second series of experiments, we explored the relationship between lymphocyte susceptibility to toxin and PI-3,4,5-P3 levels.
We first lowered PI-3,4,5-P3 levels in Jurkat cells by using inhibitors of PI3K. Jurkat cells were pretreated for 30 min with 250 nM
wortmannin or 40 M LY290004; Cdt holotoxin was added and,
16 h later, the cells were assessed for cell cycle distribution. As
shown in Fig. 9B, control cells exhibited 14.2% G2 cells while the
addition of 40 pg/ml CdtABC increased the percentage of G2 cells
to 54.5%. Pretreatment with either wortmannin or LY290004 reduced Cdt-induced accumulation of G2 cells to 35 and 22.0%,
respectively. Under these conditions, the drugs alone had minimal
affect on cell cycle progression. Thus, reducing PI-3,4,5-P3 synthesis protects cells from Cdt-induced G2 arrest.

PTEN and SHIP1, both PI-3,4,5-P3 phosphatases, regulate cell
proliferation and survival by opposing the action of PI3K, thereby,
maintaining low levels of PI-3,4,5-P3 and blocking activation of
Akt (37–39). As a consequence of this mode of action, PTEN and
SHIP function as tumor suppressors (25, 26). Indeed, somatic deletions or mutations have been identified in a variety of cancers
making them, along with p53, the most commonly mutated genes
in human cancers (40). Of particular relevance, cell lines derived
from leukemia and lymphoma patients often exhibit defects in either one or both of these lipid phosphatases (25, 26). In the final
series of experiments, we took advantage of such naturally occurring defects of these phosphatases in lymphoid cell lines and assessed their relative sensitivity to Cdt. Jurkat cells have been
shown to be deficient in both PTEN and SHIP resulting in relatively high levels of PI-3,4,5-P3 (25, 26). As shown in Fig. 10,
Jurkat cells exhibit the highest sensitivity to Cdt; the percentage of
G2 cells increased from 12.5% in untreated cultures to 21 and 59%
in the presence of 0.32 and 40 pg/ml Cdt. In contrast, the cutaneous
T cell lymphoma cell line, Hut78, which contains functional levels
of SHIP1 and PTEN as well as low levels of PI-3,4,5-P3, was
resistant to the toxin at all concentrations tested. Molt and CEM
cells are deficient in PTEN, but have functional SHIP1 activity;
these cells exhibit susceptibility to Cdt holotoxin that was less than
that observed with Jurkat cells. The percentage of G2 cells increased to 13 (Molt) and 15% (CEM) in the presence of 0.32 pg/ml
Cdt and to 41 (Molt) and 32% (CEM) in the presence of 40 pg/ml
toxin. Thus, it appears that lymphoid cell susceptibility to Cdtinduced G2 arrest is dependent upon the endogenous levels of
PI-3,4,5-P3 and possibly the cells dependence on this lipid for
proliferation and survival.

Discussion
Over the past several years, lipids in general, and PI-3,4,5-P3 in
particular, have become recognized for their central role in regulating an array of biological responses which include cell growth,
proliferation, and survival. PI-3,4,5-P3 is normally maintained at
low levels and increases rapidly in response to a variety of signals
that involve plasma membrane recruitment and activation of PI3K.
Normal cell function requires that PI-3,4,5-P3 levels be tightly regulated; three enzymes, PTEN, SHIP1, and SHIP2, have been
shown to play critical roles in this capacity (37–39). The tumor
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FIGURE 10. Comparison of lymphoid cell line susceptibility to Cdtinduced G2 arrest. Jurkat cells (F), Hut78 cells (), Molt cells (f), and
CCRF-CEM cells (⽧) were treated with varying amounts of CdtABC and
incubated for 18 h. The cells were then harvested, stained with propidium
iodide, and analyzed by flow cytometry for cell cycle distribution. Data are
plotted as percent G2 cells vs CdtABC concentration. Results represent the
mean ⫾ SD of three experiments.
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to contain different levels of PI-3,4,5-P3 resulting from inherent
defects in lipid phosphatase activity. It is of particular relevance to
this study that Jurkat cells have been shown to be deficient in both
functional PTEN and SHIP1 and as a result these cells have high
basal levels of PI-3,4,5-P3 (25, 26). It should be noted that elevated
levels of PI-3,4,5-P3 have been shown to be critical for the survival
of Jurkat and many other leukemic cell lines. Thus, of the cells
examined, Jurkat cells were the most sensitive to Cdt-induced G2
arrest; this is consistent with their dependence on elevated levels of
PI-3,4,5-P3 for survival. In contrast, HUT78 cells, a cutaneous T
cell lymphoma cell line that contains functional levels of both
PTEN and SHIP1 and concomitant lower intracellular levels of
PI-3,4,5-P3, were resistant to the effects of Cdt at the concentrations used in this study. Finally, CEM and Molt cells contain normal SHIP1 expression and activity, but lack PTEN. These cells
were responsive to Cdt, albeit, they exhibited reduced sensitivity
than Jurkat cells.
It should be noted that current dogma is that CdtB toxicity is the
result of DNase I-like activity whereby the toxin cleaves DNA and
in turn activates cell cycle checkpoints (18, 21). As demonstrated
in this study and by others, CdtB exhibits ⬍0.01% of the activity
of bovine DNase I (13, 20); in contrast, CdtB is approximately
one-tenth as active as PTEN. In addition to partial sequence and
structural homology, the link between CdtB and DNase I was initially based upon two lines of investigation. One approach used
mutation of the cdtB gene at loci that are believed to be critical to
DNase activity (13, 18, 20). We now demonstrate that many of
these mutations also result in a decline in PI-3,4,5-P3 phosphatase
activity. Other investigators have demonstrated that Cdt exhibits
DNase activity by its ability to denature or relax supercoiled plasmid DNA (13, 14, 20, 45). Most of these studies used large quantities of Cdt holotoxin or the CdtB subunit and even under these
conditions relatively low levels of DNA fragmentation was observed. In another study, HeLa cells were treated with Cdt and
assessed for both cell cycle arrest and the presence of DNA strand
breaks (46). In addition to using relatively large doses of toxin,
these studies do not discriminate between direct DNase activity
associated with Cdt and the possibility of indirect effects whereby
toxin treatment leads to activation of DNase endogenous to the
cell. Indeed, our own studies support the notion that the vast majority of DNA fragmentation that we and others have reported in
association with exposure to Cdt result from activation of the apoptotic cascade (10, 12, 47, 48). Nonetheless, our studies do not
eliminate the possibility that Cdt may indeed exhibit dual functions
whereby DNase activity is important for toxicity in some cell types
while lipid phosphatase activity is critical for toxicity in other cells
such as lymphocytes. It should be noted that in most cases, enzymes exhibit fairly strict specificity for one substrate, or at the
most a few related substrates, as dictated by the active site constraints. In this particular case, one would not expect that an enzyme could evolve to have very strong DNase and lipid phosphatase activities, simply because the corresponding substrates are too
different. However, a putative lipid phosphatase could potentially
evolve into low-activity nuclease (if this was ultimately beneficial
to its overall function) while giving up only part of its original
phosphatase activity.
Collectively, our observations demonstrate that the active Cdt
subunit, CdtB, is capable of functioning as a PI-3,4,5-P3 phosphatase and that this activity appears to be critical to toxin-induced G2
arrest in lymphocytes. Two lines of evidence support the candidacy of PI-3,4,5-P3 as the major cellular target of CdtB. First, as
noted earlier, the in vitro phosphatase activity of CdtB is much
more robust than its nuclease activity, at least in relative terms
when compared with other similar enzymes. Second, the results of
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suppressor phosphatase, PTEN, was originally identified as a dualspecificity protein phosphatase. However, PTEN appears to be a
poor protein phosphatase and its biologically relevant substrates
are 3-phospholipids, specifically PI-3,4,5-P3 which is hydrolyzed
to PI-4,5-P2. SHIP1 and SHIP2 are inositol 5-phosphatases;
whereas SHIP2 is ubiquitously expressed, SHIP1 appears to be
found in a limited subset of cells including most immune cells.
Both SHIP enzymes hydrolyze PI-3,4,5-P3 to PI-3,4-P2 and inositol 1,3,4,5-tetrakisphosphate to inositol 1,3,4 triphosphate.
Therefore, it is noteworthy that our observations clearly demonstrate that the active Cdt subunit, CdtB, is capable of hydrolyzing PI-3,4,5-P3 and appears to function as an inositol
5-polyphosphate phosphatase similar to the SHIP enzymes.
However, unlike the SHIPs, CdtB does not hydrolyze inositol
1,3,4,5-tetrakisphosphate.
The relationship between CdtB and SHIP is not surprising since
the initial observations of Dlakić (24) indicated sequence and
structural homology between CdtB and a larger group of divergent
enzymes that includes inositol polyphosphate 5-phosphatases.
These enzymes have been predicted, based on sequence analysis,
to be similar in fold and mechanism to DNase I and related metaldependent phosphohydrolases (31, 41– 44). Recently, the Cdt holotoxin was crystallized and analyzed by x-ray crystallography (13,
30). Of particular relevance to this study, the analysis reveals
structural similarity with not just DNase I, but equal structural
homology with inositol polyphosphate 5-phosphatase (Fig. 1). Despite the lack of significant pairwise sequence identity, structural
similarity was predicted on the basis of sensitive multiple sequence
alignments as an extension of an earlier discovery of homology
between the nucleases and bacterial sphingomyelinase (31). Analysis of CdtB indicates that its structure can be superimposed on
inositol polyphosphate 5-phosphatase with an RMSD of 3.5 Å over
183 C␣ atoms; this compares to structural overlap of CdtB with
DNase I with a root-mean-square deviation of 3.1 Å over 207 C␣
atoms. Moreover, additional analysis of Cdt sequence homology
with inositol polyphosphate 5-phosphatases demonstrate conserved regions corresponding to the active site (Fig. 5). To further
explore this relationship, we generated several CdtB mutants that
involve amino acid substitutions in the putative catalytic site
(CdtBH160Q, CdtBH274Q, CdtBD199S, and CdtBR117A). In all instances, the mutants exhibited reduced phosphatase activity when
compared with CdtBWT. Furthermore, each of the mutants lost the
ability to induce Jurkat cells to undergo G2 arrest in the presence
of the CdtA and CdtC subunits. These mutants also exhibited reduced DNase I-like activity when they were assessed for their
ability to relax supercoiled plasmid DNA. It is noteworthy, however, that the DNase activity of one mutant, CdtBH274Q, was not
altered. Thus, it appears that there is a good correlation between
the ability of CdtB to function as a PI-3,4,5-P3 phosphatase and its
toxicity in lymphocytes.
The relationship between lipid phosphatase activity and the ability of Cdt to intoxicate lymphocytes was further explored using
two lines of investigation. First, we demonstrate that exposure of
Jurkat cells to Cdt results in both a dose- and time-dependent reduction of the intracellular levels of PI-3,4,5-P3. It should be noted
that these effects occur at Cdt concentrations (50 pg/ml) equivalent
to those that also induce maximal G2 arrest in lymphocytes. A
second series of experiments demonstrate that lymphocyte susceptibility to Cdt is dependent upon the cellular content of PI-3,4,5-P3.
In this regard, we first used two PI3K inhibitors, wortmannin and
LY290004, to reduce Jurkat cell PI-3,4,5-P3 levels; cells were then
assessed for susceptibility to the toxin. Both PI3K inhibitors protected Jurkat cells from Cdt-induced G2 arrest. We also compared
Cdt sensitivity of several lymphoid cell lines that have been shown
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mutagenesis experiments done in this study and by Nesic et al. (13)
are fully compatible with the phosphatase function. For example,
the CdtBR117A mutation, either alone or in the context of the triple
DNA-binding mutant, eradicates the G2 arrest normally induced by
CdtBWT without significantly affecting the DNase activity (13); we
demonstrate that this mutation severely affects the PI-3,4,5-P3
phosphatase activity of CdtB. Two arginine residues in the active
site of inositol phosphate 5-phosphatases interact with either phosphate or hydroxyl groups of inositol and a similar function of R117
could explain the failure of our kinetic measurements to detect any
product with the CdtBR117A mutant (31). It is worth noting that the
mutation of the flanking valine, V118E, also eliminates the G2
arrest normally induced by CdtBWT, even though this particular
mutation was expected to boost the DNase activity of CdtB (13).
Overall, it appears that the ability of CdtB and its mutants to cause
cell cycle arrest always correlates with their phosphatase activities
and only sometimes with their DNase activities.
In summary, we propose that lymphocytes represent one of the
primary in vivo targets of Cdt; this is based in part upon their
exquisite sensitivity to toxin-induced cell cycle arrest. We further
propose that the underlying basis for this heightened sensitivity to
the toxin is related to a combination of CdtB-associated lipid phosphatase activity and lymphocyte dependence upon PI-3,4,5-P3.
Our observations suggest that CdtB, like SHIP1 and PTEN, mediates its regulatory effects by dephosphorylating PI-3,4,5-P3 and
thereby modulating the activity of pleckstrin homology containing
proteins such as Akt. In this regard, it is well-established that antigenic and mitogenic activation leading to clonal expansion of
lymphocytes is dependent upon increases in PI-3,4,5-P3 and subsequent activation of the Akt pathway. This mechanism of action
also accounts for the heightened sensitivity of leukemic cells to
Cdt because mutations of PTEN and/or SHIP1 appears to be a
common feature of cells such as Jurkat. Therefore, we propose that
the mechanism of action for Cdt in lymphocytes, and other cell
types, involves the depletion of PI-3,4,5-P3 and a concomitant inactivation of the Akt pathway. Indeed, it has been shown that inactivation of Akt can lead to both cell cycle arrest and the activation of the apoptotic cascade, events that are also associated with
the action of Cdt. In conclusion, it is likely that as a result of CdtB
phosphatase activity, lymphocytes undergo cell cycle arrest resulting in impaired host immunity. In vivo, these events most likely
create a situation that favors chronic infection and thereby contribute to the pathogenesis of disease associated with Cdt-producing organisms such as A. actinomycetemcomitans.
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